Dr. Darrin Menard, MD

NPI: 1417982422
Total Payments
$15,683
2024 Payments
$1,854
Companies
54
Transactions
1,130
Medicare Patients
16,050
Medicare Billing
$986,259

Payment Breakdown by Category

Food & Beverage$15,620 (99.6%)
Education$63.35 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,620 1,117 99.6%
Education $63.35 13 0.4%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $2,238 157 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,786 111 $0 (2024)
Novo Nordisk Inc $1,547 127 $0 (2024)
ABBVIE INC. $1,090 75 $0 (2024)
Amgen Inc. $1,059 67 $0 (2024)
Allergan, Inc. $821.82 67 $0 (2020)
Lilly USA, LLC $814.23 56 $0 (2024)
PFIZER INC. $597.52 54 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $590.46 44 $0 (2023)
Merck Sharp & Dohme LLC $503.28 38 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,854 108 AstraZeneca Pharmaceuticals LP ($309.60)
2023 $1,858 116 AstraZeneca Pharmaceuticals LP ($336.97)
2022 $1,862 126 AstraZeneca Pharmaceuticals LP ($266.79)
2021 $1,986 136 AbbVie Inc. ($341.64)
2020 $1,783 134 GlaxoSmithKline, LLC. ($272.38)
2019 $1,720 143 GlaxoSmithKline, LLC. ($226.87)
2018 $2,291 182 GlaxoSmithKline, LLC. ($374.59)
2017 $2,331 185 Allergan Inc. ($369.34)

All Payment Transactions

1,130 individual payment records from CMS Open Payments — Page 1 of 46

Date Company Product Nature Form Amount Type
12/19/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $19.06 General
Category: Biological
12/17/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $13.99 General
Category: Inflammation
12/12/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $17.82 General
Category: TESTOSTERONE REPLACEMENT THERAPY
12/09/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.53 General
Category: Diabetes
12/02/2024 Tolmar, Inc. JATENZO (Drug) Food and Beverage Cash or cash equivalent $16.11 General
Category: HORMONE REPLACEMENT
11/26/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $18.65 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/19/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.34 General
Category: RESPIRATORY
11/18/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $18.70 General
Category: Respiratory
11/14/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $19.21 General
Category: RESPIRATORY
11/12/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.08 General
Category: Cardiovascular and Metabolism
11/11/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $19.57 General
Category: Cardio-renal
11/07/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $19.95 General
Category: Diabetes
10/31/2024 Noven Therapeutics, LLC Xelstrym (Drug) Food and Beverage In-kind items and services $23.38 General
Category: ADHD
10/29/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.22 General
Category: Respiratory
10/28/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $14.28 General
Category: GASTROENTEROLOGY
10/22/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $18.74 General
Category: Biological
10/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.12 General
Category: RESPIRATORY
10/17/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $19.19 General
Category: Oncology
10/10/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $16.42 General
Category: ANTILIPEMIC AGENTS
10/07/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $22.88 General
Category: TESTOSTERONE REPLACEMENT THERAPY
10/01/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $13.39 General
Category: NEUROSCIENCE
10/01/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $8.19 General
Category: NEUROSCIENCE
09/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.90 General
Category: Respiratory
09/23/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $11.97 General
Category: VACCINES
09/19/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.77 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 45 3,831 7,886 $613,327 $212,708
2022 44 3,602 6,884 $564,599 $189,890
2021 56 4,329 7,066 $577,123 $308,078
2020 50 4,288 7,190 $533,222 $275,583
Total Patients
16,050
Total Services
29,026
Medicare Billing
$986,259
Procedure Codes
195

All Medicare Procedures & Services

195 procedure records from CMS Medicare Utilization — Page 1 of 8

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 674 1,702 $229,770 $72,425 31.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 482 1,079 $102,505 $42,727 41.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 611 611 $82,485 $26,577 32.2%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 120 158 $8,670 $6,307 72.7%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 65 65 $11,700 $6,063 51.8%
99496 Transitional care management services for problem of high complexity Office 2023 68 79 $22,910 $5,157 22.5%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 62 92 $8,740 $5,091 58.3%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 38 38 $6,610 $4,868 73.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 262 542 $13,550 $4,803 35.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 48 48 $8,640 $4,569 52.9%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 103 246 $8,590 $3,950 46.0%
71046 X-ray of chest, 2 views Office 2023 95 115 $10,120 $2,583 25.5%
20610 Aspiration and/or injection of fluid from large joint Office 2023 39 57 $8,875 $2,357 26.6%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 31 36 $7,740 $2,162 27.9%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 44 54 $4,050 $2,005 49.5%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 17 17 $6,766 $1,939 28.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 32 34 $6,460 $1,735 26.9%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 17 19 $2,622 $1,592 60.7%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 24 42 $1,890 $1,435 75.9%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2023 31 50 $6,250 $1,398 22.4%
93971 Ultrasound study of one arm or leg veins with compression and maneuvers Office 2023 15 16 $2,500 $1,315 52.6%
72100 X-ray of lower and sacral spine, 2-3 views Office 2023 42 45 $3,870 $1,137 29.4%
69210 Removal of impacted ear wax Office 2023 34 38 $2,470 $1,091 44.2%
76770 Complete ultrasound scan behind abdominal cavity Office 2023 14 14 $3,640 $946.68 26.0%
73560 X-ray of knee, 1-2 views Office 2023 35 44 $2,200 $936.32 42.6%

About Dr. Darrin Menard, MD

Dr. Darrin Menard, MD is a Family Medicine healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417982422.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darrin Menard, MD has received a total of $15,683 in payments from pharmaceutical and medical device companies, with $1,854 received in 2024. These payments were reported across 1,130 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($15,620).

As a Medicare-enrolled provider, Menard has provided services to 16,050 Medicare beneficiaries, totaling 29,026 services with total Medicare billing of $986,259. Data is available for 4 years (2020–2023), covering 195 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Lafayette, LA
  • Active Since 07/11/2006
  • Last Updated 09/15/2020
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1417982422

Products in Payments

  • TRELEGY ELLIPTA (Drug) $1,318
  • FARXIGA (Drug) $1,018
  • Ozempic (Drug) $858.90
  • VYVANSE (Drug) $541.07
  • VRAYLAR (Drug) $493.52
  • UBRELVY (Drug) $466.60
  • Otezla (Drug) $449.50
  • BREZTRI (Drug) $402.08
  • QULIPTA (Drug) $355.29
  • TRULICITY (Drug) $354.86
  • XARELTO (Drug) $352.34
  • BREO (Drug) $321.33
  • MOUNJARO (Drug) $319.65
  • Vascepa (Drug) $303.43
  • XYOSTED (Drug) $284.47
  • Victoza (Drug) $263.58
  • LINZESS (Drug) $259.85
  • TRINTELLIX (Drug) $256.01
  • ANORO (Drug) $251.20
  • Prolia (Biological) $243.83

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Lafayette